Heritage Cannabis Holdings Corp. Commends Constellation Brands Strategic Investment in Canopy Growth

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Return to homepage

(TheNewswire)



Vancouver, B.C. / TheNewswire / August 16, 2018 – HERITAGE CANNABIS HOLDINGS CORP. (CSE: CANN) (“Heritage or Company”) and it’s subsidiary PhyeinMed Inc., a licensed producer by Health Canada commends Constellation Brands for supporting Canopy Growth with their recent investment of potentially $5 Billion (CAN) to address the recreational and medical markets.  

In March of this year, PhyeinMed Inc signed an updated wholesale agreement with Canopy Growth Corp., to supply cannabis and cannabis products to the marketplace via Tweed Main Street website. This amended three-year agreement addresses the supply of both recreational and medicinal cannabis.

“Constellation’s expanded investment with Canopy Growth, substantiates our belief that both the Canadian and global cannabis market will continue to see significant growth”. states Clint Sharples, Chairman of Heritage Cannabis Holdings, “we agree with this vision, and we want to make sure Heritage is properly positioned to take advantage of this progression.”

About Heritage Cannabis Holdings Corp.

The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada license holder under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a Parent and Development Company with strategic plans to continue to acquire Cannabis related companies.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION

 

“Jag Bal”

 

Jagdip Bal

President and CEO

 

For more information contact:

Jag Bal

Tel:  604-628-1767

[email protected]       


The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

 

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

  

Copyright (c) 2018 TheNewswire - All rights reserved.